Cargando…
Microvascular Dynamics and Hemodialysis Response of Patients With End-Stage Renal Disease
In our previous analysis of three sets of hemodialysis studies, we found that patients possessing higher hematocrit have a higher filtration coefficient KSo and more fluid being restituted from the tissue. A new dynamic analysis is developed to reveal how the plasma protein concentration, restitutio...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159995/ https://www.ncbi.nlm.nih.gov/pubmed/35662845 http://dx.doi.org/10.3389/fbioe.2022.836990 |
_version_ | 1784719179699453952 |
---|---|
author | Lee, Jen-Shih Lee, Lian-Pin |
author_facet | Lee, Jen-Shih Lee, Lian-Pin |
author_sort | Lee, Jen-Shih |
collection | PubMed |
description | In our previous analysis of three sets of hemodialysis studies, we found that patients possessing higher hematocrit have a higher filtration coefficient KSo and more fluid being restituted from the tissue. A new dynamic analysis is developed to reveal how the plasma protein concentration, restitution volume, and plasma volume are changing over the time course of 240 min hemodialysis. For patients with the filtration coefficient KSo as 0.43 or 5.88 ml/min/mmHg, we find that the restitution rate would reach 50% of the extraction rate in 5.3 or 57.4 min, respectively. By the end of hemodialysis, the restitution rate of both patients asymptotically approaches a value of 0.93 ml/min which is slightly higher than the extraction rate of 9.03 ml/min. The plasma volume drops by 10% of the total plasma volume in 11 min for patients with low KSo and drops by 2.1% and turns around to an increasing trend in 5.6 min for patients with high KSo. These results suggest that the filtration coefficient acts like a facilitator in restituting more fluid from the tissue to compensate for the loss of plasma volume due to extraction. The hematocrit data of three sets of hemodialysis also indicate that significant microvascular blood volume is shifted from small veins toward the venous side of macrocirculation. A better understanding of how the factors examined here cause hypovolemia can be the basis for one to modify the hemodialysis process such that the development of hypovolemia can be avoided over the course of hemodialysis. |
format | Online Article Text |
id | pubmed-9159995 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-91599952022-06-03 Microvascular Dynamics and Hemodialysis Response of Patients With End-Stage Renal Disease Lee, Jen-Shih Lee, Lian-Pin Front Bioeng Biotechnol Bioengineering and Biotechnology In our previous analysis of three sets of hemodialysis studies, we found that patients possessing higher hematocrit have a higher filtration coefficient KSo and more fluid being restituted from the tissue. A new dynamic analysis is developed to reveal how the plasma protein concentration, restitution volume, and plasma volume are changing over the time course of 240 min hemodialysis. For patients with the filtration coefficient KSo as 0.43 or 5.88 ml/min/mmHg, we find that the restitution rate would reach 50% of the extraction rate in 5.3 or 57.4 min, respectively. By the end of hemodialysis, the restitution rate of both patients asymptotically approaches a value of 0.93 ml/min which is slightly higher than the extraction rate of 9.03 ml/min. The plasma volume drops by 10% of the total plasma volume in 11 min for patients with low KSo and drops by 2.1% and turns around to an increasing trend in 5.6 min for patients with high KSo. These results suggest that the filtration coefficient acts like a facilitator in restituting more fluid from the tissue to compensate for the loss of plasma volume due to extraction. The hematocrit data of three sets of hemodialysis also indicate that significant microvascular blood volume is shifted from small veins toward the venous side of macrocirculation. A better understanding of how the factors examined here cause hypovolemia can be the basis for one to modify the hemodialysis process such that the development of hypovolemia can be avoided over the course of hemodialysis. Frontiers Media S.A. 2022-05-18 /pmc/articles/PMC9159995/ /pubmed/35662845 http://dx.doi.org/10.3389/fbioe.2022.836990 Text en Copyright © 2022 Lee and Lee. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Bioengineering and Biotechnology Lee, Jen-Shih Lee, Lian-Pin Microvascular Dynamics and Hemodialysis Response of Patients With End-Stage Renal Disease |
title | Microvascular Dynamics and Hemodialysis Response of Patients With End-Stage Renal Disease |
title_full | Microvascular Dynamics and Hemodialysis Response of Patients With End-Stage Renal Disease |
title_fullStr | Microvascular Dynamics and Hemodialysis Response of Patients With End-Stage Renal Disease |
title_full_unstemmed | Microvascular Dynamics and Hemodialysis Response of Patients With End-Stage Renal Disease |
title_short | Microvascular Dynamics and Hemodialysis Response of Patients With End-Stage Renal Disease |
title_sort | microvascular dynamics and hemodialysis response of patients with end-stage renal disease |
topic | Bioengineering and Biotechnology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159995/ https://www.ncbi.nlm.nih.gov/pubmed/35662845 http://dx.doi.org/10.3389/fbioe.2022.836990 |
work_keys_str_mv | AT leejenshih microvasculardynamicsandhemodialysisresponseofpatientswithendstagerenaldisease AT leelianpin microvasculardynamicsandhemodialysisresponseofpatientswithendstagerenaldisease |